ning treatment and prevention trials with amyloid-lowering agents in AD. O1-03-03 CEREBRAL AMYLOID ANGIOPATHY IN ALZHEIMER’S DISEASE IS ASSOCIATEDWITH INCREASED BLOOD-BRAIN BARRIER PERMEABILITY: A QUANTITATIVE [11C]PIB-PET STUDY
暂无分享,去创建一个
A. Fagan | D. Marcus | J. Morris | C. Jack | P. Thompson | M. Raichle | C. Rowe | A. Saykin | A. Brickman | V. Buckles | R. Mayeux | K. Kantarci | M. Rossor | S. Salloway | R. Bateman | C. Xiong | A. Goate | N. Cairns | Tyler Blazey | K. Moulder | B. Ghetti | E. McDade | J. Ringman | T. Benzinger | N. Fox | S. Correia | G. Preboske | R. Hornbeck | R. Sperling | P. Schofield | M. Weiner